-
AnaptysBio raises $75 million in initial public offering
27 Jan 2017 02:21 GMT
… $75 million Thursday in an initial public offering, making it the first U … for inflammatory drugs and with Tesaro for cancer therapies.
Credit Suisse …
-
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More
04 Oct 2019 11:35 GMT
Xconomy
National —
It’s been a strange up and down ride for PARP inhibitors, a relatively new class of cancer drugs.
Named for the tumor protein they target, PARPs rebounded after a big clinical setback in 2011 and have been at the center of many buyouts …
-
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More
19 Jul 2019 14:21 GMT
Xconomy
National —
The opioid crisis reaches all corners of the nation, and newly released data this week revealed how the growth of the epidemic tracked with a massive increase in the production and distribution of these drugs.
From 2006 to 2012, the …
-
IPO Update: Ideaya Biosciences Readies Terms For IPO
15 May 2019 17:45 GMT
… : Immunocore AstraZeneca (AZN) Clovis (CLVS) Tesaro (GSK) Pfizer (PFE) Agios (AGIO … Seeking Alpha Marketplace research service IPO Edge includes my full commentary … and opinion on the IPO.
Members of IPO Edge get the latest …
-
IDEAYA Biosciences Files For U.S. IPO
03 May 2019 21:00 GMT
… Immunocore AstraZeneca (AZN) Clovis (CLVS) Tesaro (GSK) Pfizer (PFE) Agios ( … Citigroup, and Jefferies. Expected IPO Pricing Date: To be announced … Alpha Marketplace research service IPO Edge includes my full … opinion on the IPO.
Members of IPO Edge get the …
-
Preclinical IPOs: Is the window starting to close?
05 Jan 2019 11:05 GMT
… almost $800million through their IPOs, despite none having permission … this year, such as Tesaro by GlaxoSmithKline and Juno …
[5] Solid Biosciences’ IPO Hits Potential Snag. Published … [6] Solid Biosciences Completes IPO. Published January 26. Available …
-
Tesaro: Quick Goodbye
03 Dec 2018 23:29 GMT
… the way. While investors in Tesaro have finally received some sort … reached a deal to acquire Tesaro for $75 per share in … of the losses incurred by Tesaro, and now thus GSK. What … research on all the latest IPOs, M&A activity and …
-
GlaxoSmithKline Strikes $5B M&A Deal With Tesaro In Quest To Boost Oncology Franchise
03 Dec 2018 15:54 GMT
… plc (NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) announced … Important
The acquisition of Tesaro brings to GlaxoSmithKline a … mutation or biomarker status.
Tesaro is also working on … Dates, Clinical Trials And IPOs
Attention Biotech Investors: Mark Your …
-
The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs
15 Oct 2018 07:10 GMT
… and neck squamous cell carcinomas )
TESARO Inc (NASDAQ: TSRO) – Phase … ISRG)(after the market close)
IPOs
LogicBio Therapeutics, a pre-clinical … 6 million shares in an IPO, with an estimated price … the ticker symbol SIBN.
IPO Quiet Period Expiry
Elanco Animal …
-
China’s BeiGene raises $903m from Hong Kong IPO
03 Aug 2018 10:58 GMT
… the $1bn threshold with its IPO, but may have been affected … use the proceeds from the IPO “for clinical trials, preparation for … (Lynparza), Clovis Oncology (Rubraca) and Tesaro (Zejula).
BeiGene’s shares are …